AGP Picks
View all

Following the news from Africa

Provided by AGP

Times Reporter of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.

Press releases published on May 13, 2026

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026
Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
Lite Strategy Reports Fiscal 2026 Third Quarter Results
Globex Options Carp Fluorspar Property in Nevada to Evion Group NL of Australia
Century Therapeutics Reports First Quarter Financial Results and Business Updates 
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药
Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗,已為首位患者完成給藥
Pyxis Oncology to Participate in Upcoming Investor Conferences
Altimmune Announces First Quarter 2026 Financial Results and Business Update
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
Andera Partners Leads $20 Million Series D Financing in Rivermark Medical

Share us

on your social networks:

Sign up for:

Times Reporter of Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.